Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged patent · clear
Written by Kerry S. Taylor, Ph.D. and Michael L. Fuller On January 19, 2017, the Board issued a final written decision in World Bottling Cap, LLC v Crown Packaging Technology, Inc. (IPR2015-01651) finding the challenged claims were not unpatentably obvious…
Before turning to 2017 news, we’ll first briefly catch up on a few stories from December. In early December, the Brazilian green patent priority examination program (see my original post here and a subsequent critique of the program here ) became a…
The doctrine of definiteness requires a patent to clearly state what the inventor considers to be their invention. Of course, the PTAB interprets various claim terms when determining whether a prior art reference anticipates or renders obvious a particular…
Written by Paul Chang, Ph.D. and Brenden Gingrich, Ph.D. Anticipation by inherent disclosure requires that a single prior art reference necessarily includes the unstated limitation. The unpredictable nature of biological processes means that winning…
Since 2012, IPRs have emerged as one of the most significant developments in intellectual property. Even if you are already familiar with IPRs, these videos illustrate how actual IPR practitioners might approach some common issues. Introduction to IPRs…
The stage is being set for a coordinated attack on the patent system under the guise of making international health care more affordable. A newly released United Nations report encourages developing countries to use compulsory licenses to seize drugs,…
In what may be a first, a new U.S. patent includes a statement about the geographic location of the colorant composition. The patent – U.S. Patent No. 9,376,569 – issued June 28, 2016 and is entitled “Colorant compounds derived from…
Given the volume of district court decisions regarding Section 101, I typically don't find ones that stand out enough to warrant discussion. But last week's decision by Judge Stark in MAZ Encryption Technologies LLC v. Blackberry Corporation is an…
A number of new green patent infringement complaints were filed in July and August in the areas of advanced batteries, biofuels, LEDs, and electric motors. Advanced Batteries Dynavair LLC v. AMS USA, Inc.; Dynavair v. Atmel; Dyanavair v. Cobham Advanced…
Inter Partes Review (IPR) proceedings are limited to prior art challenges for printed prior art. Although prior art typically includes drawings that illustrate physical structures, the description of those drawings may only discuss what is illustrated and…
UCB sued Yeda for a DJ of non-infringement of US Patent No. 6,090,923 [Appeal No. 2015-1957 (Fed. Cir. September 8, 2016)].The main claim in question was directed to “A monoclonal antibody which specifically binds a human cytotoxin [having X…
The Patent Trial and Appeal Board (PTAB) decides petitions to institute post-grant proceedings, including inter partes reviews (IPRs). PTAB institution decisions, as contrasted with the merits of any final written decision, are nonappealable. Despite the…
